Insulet
PODD
#993
Rank
S$26.50 B
Marketcap
$377.79
Share price
-1.90%
Change (1 day)
42.77%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

EPS for Insulet (PODD)

EPS in 2023 (TTM): $2.33

According to Insulet's latest financial reports the company's current EPS (TTM) is $2.30. In 2022 the company made an earnings per share (EPS) of $0.09351 a decrease over its 2021 EPS that were of $0.31.

EPS history for Insulet from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.332387.86%
2022$0.09351-69.57%
2021$0.31109.09%
2020$0.15-38.89%
2019$0.24200%
2018$0.08015-113.04%
2017-$0.61-9.8%
2016-$0.68-60.77%
2015-$1.7439.78%
2014-$1.2412.05%
2013-$1.11-23.15%
2012-$1.4410.2%
2011-$1.31-36.36%
2010-$2.06-36.63%
2009-$3.25-29.36%
2008-$4.60-86.74%
2007-$34.66-64.04%
2006-$96.39122.23%
2005-$43.37

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.70-217.44%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.31-287.79%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.31-43.02%๐Ÿ‡บ๐Ÿ‡ธ USA
$18.82 718.91%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.97 72.80%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.63 58.14%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$7.25 215.66%๐Ÿ‡บ๐Ÿ‡ธ USA